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https://doi.org/10.1016/j.stemcr.2020.04.004SUMMARYHuman pluripotent stem cells (PSCs) are subject to the appearance of recurrent genetic variants on prolonged culture. We have now
found that, compared with isogenic differentiated cells, PSCs exhibit evidence of considerably more DNA damage during the S phase
of the cell cycle, apparently as a consequence of DNA replication stress marked by slower progression of DNA replication, activation
of latent origins of replication, and collapse of replication forks. As in many cancers, which, like PSCs, exhibit a shortened G1 phase
and DNA replication stress, the resulting DNA damage may underlie the higher incidence of abnormal and abortive mitoses in PSCs, re-
sulting in chromosomal non-dysjunction or cell death. However, we have found that the extent of DNA replication stress, DNA damage,
and consequent aberrant mitoses can be substantially reduced by culturing PSCs in the presence of exogenous nucleosides, resulting in
improved survival, clonogenicity, and population growth.INTRODUCTION
Human pluripotent stem cells (PSCs) often acquire genetic
changes on prolonged culture, which pose concerns for
their use in research and regenerative medicine (Amps
et al., 2011; Taapken et al., 2011). The acquisition of these
changes during culture necessarily first requires mutation
and then selection of those mutations that provide a
growth advantage. Whereas selection accounts for the
recurrent nature of the variants commonly reported
(Draper et al., 2004; Olariu et al., 2010), the mechanisms
of acquired mutation in PSCs remain largely unexplored.
Recent work has started to elucidate environmental condi-
tions that have an impact on the mutational burden of
PSCs, highlighting oxidative stress as a major contributor
to the acquisition of single nucleotide variation in PSCs
(Thompson et al., 2020). In addition to such extrinsic influ-
ences, intrinsic properties of PSCs are also thought to play a
role in the maintenance of their genome stability (Ahuja
et al., 2016). The defining features of PSCs that make
them distinct from somatic cells are the pluripotent gene
regulatory network responsible for maintaining the plurip-
otent state (Pera et al., 2000), and a rapid cell cycle due to an
abbreviated G1 compared with somatic cells (Becker et al.,
2006). In mouse embryonic stem cells (ESCs), the abbrevi-
ated G1 was shown to cause replication stress (Ahuja et al.,
2016), a collective term for interruption of theDNA replica-
tion process, whichmanifests as a slowing or stalling of the
DNA replication fork, resulting in DNA breaks upon a fork
collapse (Zeman and Cimprich, 2014). Replication stress
due to an abbreviated G1 is also implicated in cancer devel-
opment, wherein high levels of cyclin E drive the prema-Stem Cell R
This is an open access artiture entry of cells into the S phase in the absence of suffi-
cient nucleotide pools needed for normal progression of
the replication fork (Bester et al., 2011). Consequently,
the nucleotide-deficient cells exhibit replication stress, pre-
disposing them to DNA damage and subsequent genome
instability (Bester et al., 2011; Burrell et al., 2013).
A high level of DNA damage in human PSCs has been re-
ported previously (Simara et al., 2017; Vallabhaneni et al.,
2018), but the underlying causes and means of alleviating
the damage remain unknown. Here, we show that an
increased susceptibility to DNA damage in PSCs compared
with their isogenic differentiated cells is caused by persis-
tent replication stress in PSCs. Importantly, we demon-
strate that the addition of exogeneous nucleosides to the
culture medium restores the replication dynamics and
reduces the level of genome damage and incidence of
mitotic aberrations in PSCs. Finally, we show that nucleo-
side supplementation also improves survival of PSCs,
demonstrating that replication stress-associated genome
damage is a major cause of cell death in PSC cultures.RESULTS AND DISCUSSION
DNA double-strand breaks (DSBs) are a particularly detri-
mental type of DNA damage. Unrepaired, or erroneously
repaired, DSBs can jeopardize genome stability by leading
to mitotic aberrations and structural and chromosomal
instability (Ichijima et al., 2010; Janssen et al., 2011), like
those frequently observed in human PSCs (Amps et al.,
2011). The human induced PSC line MIFF1 (Desmarais
et al., 2016) exhibited an increased number of gH2AXeports j Vol. 14 j 1009–1017 j June 9, 2020 j ª 2020 The Author(s). 1009
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foci (Figure 1A), known to mark sites of DSBs, compared
with the fibroblast from which it was reprogrammed and
to its differentiated derivatives, obtained by treatment
with CHIR99021 for 5 days (Figure S1). Two other PSC lines
that we examined, TC113 (Baghbaderani et al., 2015) and
MShef11 (Thompson et al., 2020), showed a similarly
increased level of DNA damage compared with their differ-
entiated derivatives (Figures 1A and S1). These observations
were confirmed by a neutral comet assay that showed an
increased tail moment in the undifferentiated cells in
each case (Figure 1B). We also compared the growth of
MIFF1 in four commercially available feeder-free media
and found similar levels of gH2AX foci, although slightly
lower in cells grown in Nutristem (Figure S2A). Overall,
the results demonstrate that a high level of genome dam-
age is associated with the pluripotent state and decreases
upon differentiation.
A common cause of DSBs during S phase in cancer cells is
the slowing, stalling, and collapse of replication forks,
recognized as DNA replication stress (Ichijima et al.,
2010). To analyze the replication dynamics in undifferenti-
ated and differentiated cells, we utilized the DNA fiber
assay. Here, the newly synthesized DNA is pulse labeled
successively with thymidine analogs, cholorodeoxyuridine
(CldU) and iododeoxyuridine (IdU), for 20 min each and
then visualized by fluorescently labeled antibodies (Fig-
ure 1C). By measuring the total length of the CldU and
IdU labeling in each fiber, we found a decrease in the length
of newly synthesized fibers in the undifferentiated state
(Figures 1C–1E). Replication fork speed, calculated by
measuring the average length of labeled fibers, was signifi-
cantly slower in undifferentiated PSCs comparedwith their
isogenic somatic counterparts (Figures 1C, 1F, and 1G).
Further, we found an increase in the abundance of originsFigure 1. Replication Stress and a Susceptibility to DNA Damage
Data in the figure compare undifferentiated and differentiated cell sta
and with its differentiated derivative (MIFF1-Diff). TC113 and MShef
and MShef11-Diff).
(A) The number of gH2AX foci per S-/G2-phase cell. The S/G2 phase wa
individual cells and are the results from three independent experime
0.0001 (n > 100 cells per cell line per experiment).
(B) Average tail moment from neutral comet assays. Data displayed
****p < 0.0001 (nR 300 cells per cell line per experiment).
(C) Schematic of DNA fiber analysis. Sequential 20-min pulses of CldU
CldU and IdU lengths enable the analysis of replication fork dynamic
(D) Representative DNA fibers are shown for Fibroblast, MIFF1, and M
(E) Combined length of CldU and IdU in individual fibers (n > 200 fork
25th and 75th quartiles are presented. Two-tailed t test, ****p < 0.00
(F) Distribution of replication fork rates (n > 200 forks per cell line p
experiment ± SEM.
(G) Mean fork rates from (F) ± SD. Two-tailed t test, *p < 0.05, **p <
(H) Distribution of adjacent origins distance measurements (Ori-ori).
t test, ****p < 0.0001 (n > 30 per cell line, n = 3 experiments).of DNA replication as demonstrated by a decrease in repli-
cation origin-to-origin distance (Ori-ori) in PSCs (Figures
1C and 1H). Overall, these results show that DNA replica-
tion in pluripotent cells is considerably perturbed, predis-
posing them to DNA damage, notably DSBs.
The association of genome damage with the pluripotent
rather than the somatic state of the same cell line, suggests
that features linked to pluripotency impart replication
stress on PSCs. A pertinent key difference between the
pluripotent and somatic cell state is the rapid progression
of PSCs through G1, driven by atypical expression of cy-
clins (Becker et al., 2006; Ahuja et al., 2016). By time-lapse
microscopy and 5-ethynyl-20-deoxyuridine (EdU) pulse-
chase analysis, we found that the human PSC line,
MIFF1, exhibited a reduced cell-cycle time when compared
with its parent fibroblast line (Figure 2A). Specifically, the
abbreviated cell-cycle time was solely due to a truncated
G1 (Figure 2A). Consistent with the reduction in the length
of G1, cyclin D2 (CCND2) and cyclin E (CCNE1), which are
known to drive the Rb-E2F pathway and allow rapid pro-
gression of cells through G1 (Hinds et al., 1992; Lundberg
and Weinberg, 1998), were highly expressed in the undif-
ferentiated MIFF1 compared with the corresponding
parent fibroblast line (Figures 2B–2E). We confirmed these
findings in TC113 and MShef11, which also exhibited a
similar short G1 and enhanced expression of cyclin D2
and E (Figures 2A–2C).
We reasoned that the short G1 may have an impact on
genome damage of PSCs, since overexpression of cyclin
D2 and E in cancer cells has also been reported to enforce
an abbreviation of G1 and consequent replication stress,
which can be modulated by exogenous nucleosides (Bester
et al., 2011; Takano et al., 2000). We tested whether the
addition of exogenous nucleosides would improve theis a Characteristic of Undifferentiated Human PSCs
tes. MIFF1 was compared with its parent fibroblast line (Fibroblast)
11 were compared with their differentiated derivatives (TC113-Diff
s determined from nuclear DNA content. Data points in (A) represent
nts; the center line indicates the mean. Two-tailed t test, ****p <
are from three independent experiments ± SEM. Two-tailed t test,
and IdU labeled the progressing replication forks. Measurements of
s. Scale bar, 10 mm.
IFF1-Diff. Scale bar, 10 mm.
s per cell line per experiment, n = 3 experiments). Median distance,
01.
er experiment, n = 3 experiments). Data are mean values from each
0.01, ****p < 0.0001 (n = 3 experiments).
Median distance, 25th and 75th quartiles are presented. Two-tailed
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Figure 2. Cell-Cycle Dynamics and Cyclin Expression in Human
PSCs Are Candidates for Replication Stress Initiation
(A) Cell-cycle phase time determined from time-lapse microscopy
(Fibroblast, n = 44; MIFF1, n = 76; MShef11, n = 31) and EdU pulse-
chase analysis of asynchronous cells (minimum of 10,000 events
recorded during fluorescence-activated cell sorting analysis).
(B and C) RT-qPCR gene expression data from MIFF1, TC113, and
MShef11 for CCND2 (B), CCNE (C). Data in (B) and (C) are means ±
SD. Two-tailed t test, ***p < 0.001, ****p < 0.0001 (n = 3 ex-
periments).
(D and E) Representative western blot of protein expression for
cyclin D2 (D), cyclin E1 (E).replication dynamics of human PSCs. After an initial titra-
tion of nucleosides, using gH2AX as a readout of genome
damage, we chose a formulation 15mM cytidine, 15mM
guanosine, 15mM uridine, 15mM adenosine, and 6mM
thymidine. The addition of these exogenous nucleosides
increased DNA fiber lengths and replication fork speed in
MIFF1 to levels comparable with those observed in its
differentiated derivatives (Figures 3A–3D compared with1012 Stem Cell Reports j Vol. 14 j 1009–1017 j June 9, 2020Figures 1D–1G). In addition, we noted fewer CldU-only
tracts, indicating fewer forks stalled prior to the addition
of the second thymidine analog, IdU (Figure 3E). There
was also a decrease in replication origin density, with
Ori-ori distances in MIFF1 now comparable with those
observed in the parent fibroblast line and following the dif-
ferentiation ofMIFF1 (Figure 3F compared with Figure 1H),
suggesting that, as a consequence of slower fork speed, the
cells were firing from dormant origins in the absence of
exogenous nucleosides. We confirmed these findings in
TC113 and MShef11, which show a similar increase in
replication fork speed and Ori-ori distance with the addi-
tion of exogenous nucleosides (Figures S2B–S2F). Under
these conditions we observed a marked decrease in the
frequency of DSBs in MIFF1, TC113, and MShef11 as
indicated by a reduction in the number of gH2AX foci
per S-phase and G2-phase cells upon addition of nucleo-
sides (Figures 3G and S2G) and a decrease in tail moment
measured using the neutral comet assay (Figure 3H). Simi-
larly, exogenous nucleosides also reduced the number of
gH2AX foci when the cells were cultured in alternative hu-
man PSC culture media, Nutristem and E8 (Figure S2H),
while also retaining the ability to differentiate (Figure S3).
Overall, these results indicate that susceptibility to DNA
damage observed in the undifferentiated PSCs is a conse-
quence of replication stress that can be alleviated by exog-
enous nucleosides.
A detrimental consequence of replication stress is the
presence of under-replicated regions that can persist into
mitosis and hinder chromosome separation (Bester et al.,
2011; Burrell et al., 2013; Ichijima et al., 2010). This in
turn can lead to mitotic aberrations, including chromo-
some bridges, lagging chromosomes, and the formation
of micronuclei (Crasta et al., 2012; Ichijima et al., 2010;
Janssen et al., 2011). Using time-lapse microscopy of
MIFF1 cells stably transfected with H2B-RFP to fluores-
cently label chromatin, we tracked the progression of cells
through mitosis. Consistent with previous reports (Lamm
et al., 2016; Zhang et al., 2019), we observed a high inci-
dence of mitotic errors in human PSCs. However, the inci-
dence of these errors was significantly decreased in cells
cultured in the presence of nucleosides (Figures 3I and
3J), indicating that replication stress in human PSCs is a
cause of mitotic errors.
To investigate the consequences of these observations for
the proliferation of human PSCs, we used time-lapsemicro-
scopy to track the growth of single cells through successive
divisions. When MIFF1 cells were seeded at low density,
68%of those that attachedwent on to divide in normal cul-
ture medium, whereas 79% entered mitosis in medium
supplemented with nucleosides. This is consistent with
our previous observation that human PSCs activate
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et al., 2012, 2016). Of those that did enter mitosis, 59%
went on to form colonies of two or more cells under stan-
dard culture conditions, with many cells dying after the
first and subsequent divisions (Figures 4A and S4A). By
contrast, fewer cells died following division when exoge-
nous nucleosides were added and 91% of cells went on to
form colonies (Figures 4A and S4B) with substantially
greater final size (Figure 4B). In the absence of added nucle-
osides, there was a consistently higher number of abortive
cell divisions involving the death of both daughter cells
(Figures 4C and 4D), a result that would be anticipated if
themitotic errors caused by DNA replication stress are cata-
strophic for both daughter cells.
Taken together, our results demonstrate that human
PSCs, compared with somatic cells, are predisposed to
high levels of replication stress, manifest by slower rates
ofDNA synthesis, activation of latent origins of replication,
and the stalling of replication forks. One consequence is
their susceptibility to double-stranded DNA breaks that,
in turn, may lead to genomic rearrangements during
mitosis (Ichijima et al., 2010; Janssen et al., 2011). These re-
sults reflect the requirement for rapid replication of human
PSCs enabled by a truncated G1 (Becker et al., 2006, 2010)
that impairs the preparation of these cells for the ensuing
DNA replication. However, a further feature of human
PSCs is that, unlike somatic cells, they tend to undergo
apoptosis in response to replication stress, so minimizing
the appearance of mutant cells. This might reflect the de-
mands of cell proliferation in the early embryo in which
any genomic damage in even one cell could be catastrophic
for the whole embryo (Desmarais et al., 2012, 2016).
Indeed, in a separate study, we have found that the overall
mutation rate in human PSCs is rather low (Thompson
et al., 2020), despite their propensity to DNA damage.
Nevertheless, that human PSCs tend to accumulate partic-Figure 3. Exogenously Supplied Nucleosides Alleviate Replication
(A) Representative images of DNA fibers in the absence of nucleosi
conditions. Scale bar, 10 mm.
(B) Combined length of CldU and IdU in individual fibers (n > 200 fork
25th and 75th quartiles are presented. Two-tailed t test, ***p < 0.001
(C) Distribution of replication fork rates (n > 200 forks per condition
(D) Average fork rates from (C). Data are means ± SD. Two-tailed t te
(E) Frequency of CldU-only tracts that denote a stalled replication for
Data are means ± SD. Two-tailed t test, *p < 0.05.
(F) Distribution of adjacent origins distance measurements (Ori-ori).
t test, ****p < 0.0001 (n > 150 per cell line, n = 3 experiments).
(G) gH2AX foci per S-/G2-phase cell (determined from DNA content).
line indicates the mean. Two-tailed t test, ****p < 0.0001 (n > 100
(H) Average tail moment from neutral comet assay experiments. Data
condition per experiment, n = 3 experiments).
(I and J) Mitotic errors observed from fluorescently labeled chromat
White arrows point to mitotic error in each case. Scale bar, 10 mm. Ave
Unpaired t test, **p < 0.01 (n = 13–43 mitosis assessed per conditio
1014 Stem Cell Reports j Vol. 14 j 1009–1017 j June 9, 2020ular recurrent mutations and genomic rearrangements,
most likely reflects selection for growth advantages among
those few variants that escape apoptosis. It is notable that
resistance to apoptosis is a common feature of many recur-
rent variants that do arise in human PSCs (Avery et al.,
2013; Barbaric et al., 2014; Merkle et al., 2017). Our obser-
vation that exogenous nucleosides substantially reduced
DNA replication stress in human PSCs, perhaps compen-
sating for metabolic changes that stem from their short-
ened G1 and relaxed G1/S transition, provides a means to
reduce the incidence of recurrent genetic changes that
may compromise the use of human PSCs for disease
modeling and regenerative medicine.EXPERIMENTAL PROCEDURES
Human Pluripotent Stem Cell Culture
Two human iPSC lines, MIFF1 and TC113, and one human ESC
line, MShef11, were used in this study. MIFF1 had been reprog-
rammed at the University of Sheffield, Centre for Stem Cell
Biology, from a human foreskin fibroblast, CCD-112Sk (ATCC,
CRL-2429) using a vector-free mRNA reprogramming system
(Desmarais et al., 2016) (hPSCreg: https://hpscreg.eu/cell-line/
UOSi001-A). The second human iPSC line, TC113, was acquired
from RUCDR Infinite Biologics. It had been reprogrammed
from CD34+ umbilical cord blood cells using a non-integrating
episomal vector reprogramming system (Baghbaderani et al.,
2015) (hPSCreg: https://hpscreg.eu/cell-line/RUCDRi002-A).
Finally, the human ESC line, MShef11, had been isolated at the
University of Sheffield, Centre for Stem Cell Biology, under good
manufacturing practice-like conditions in a cleanroom setting
(HFEA license R115-8-A (Centre 0191) and HTA license 22510).
The fresh embryo was a surplus/unsuitable embryo for in vitro
fertilization treatment, donated from the assisted conception
unit and cultured to the blastocyst stage using in vitro fertilization
medium (Medicult) before explantation onto human feedersStress in Human PSCs
des (NUC) and in the presence of exogenous nucleoside (+NUC)
s per cell line per experiment, n = 3 experiments). Median distance,
.
per experiment, n = 3 experiments). Data are means ± SEM.
st, *p < 0.05 (n = 3 experiments).
k (n > 700 forks per condition per experiment, n = 3 experiments).
Median distance, 25th and 75th quartiles are presented. Two-tailed
Each data point is the measurement of an individual cell; the center
cells per condition per experiment, n = 3 experiments).
are means ± SD. Two-tailed t test, ***p < 0.001 (nR 300 cells per
in (histone H2B-RFP). Representative images of mitotic errors (I).
rage frequency of mitotic errors observed (J). Data are means ± SD.
n per experiment, n = 4 experiments).
AB C D
Figure 4. Exogenous Nucleosides Improve Survival and the Ability of Human PSCs to Re-enter the Cell Cycle Post Plating
(A) Time-lapse data tracing the growth of individual MIFF1 cells that reach the first cell division plotted as lineage trees. A random sample
of 20 cells (full set of 75 cells shown in Figure S4) grown without exogenous nucleosides (top, NUC) and in the presence of exogenous
nucleosides (bottom, +NUC). Where the trees fork indicates a cell division, red crosses show cell death, and surviving cells at the end of the
time lapse are noted with a green triangle. Time is displayed on the y axis.
(B–D) Summary data of the lineage tree analysis (B). Histogram of the distribution colony sizes at the end of the time-lapse experiment
(C). Schematic illustrating the scoring method used in (D). After each division, the fate of the daughter cells was recorded: both daughter
cells surviving (SS), one daughter cell survives and one dies (SD), or both daughter cells die (DD). (D) Individual bar charts show the
frequency of SS, SD and DD daughter cell fates following the first, second and third divisions (left to right) after plating (D). Cell culture
media without exogenous nucleosides (black) and grown in the presence of exogenous nucleosides (red) conditions are shown.(Thompson et al., 2020) (hPSCreg: https://hpscreg.eu/cell-line/
UOSe015-A).
These PSCs were all cultured on vitronectin (VTN-N) recombi-
nant human protein (Thermo Fisher Scientific, A14700). Cul-
ture vessels were coated with 200mL/cm2 of vitronectin that
had been diluted to 6mg/mL with PBS and incubated at 37C
for at least 1 h. The cells were maintained in feeder-free condi-
tions, batch fed daily with Essential 8 (Chen et al., 2011),
mTeSR1 (STEMCELL Technologies, 85850), NutriStem XF (Bio-
logical Industries, 05-100-1A) or Essential 8 medium (Chen
et al., 2011) without fibroblast growth factor 2 (FGF2) but
supplemented with StemBeads FGF2 (800mL per 100 mL)
(StemCultures, SB500), and incubated in a 37C, 5% CO2 hu-
midified incubator. Passaging of cells was performed by clump
dissociation using ReLeSR (STEMCELL Technologies, 05,873)
following the manufacturer’s guidelines.Differentiation of Human PSCs
Human PSCs were grown for 5 days in E8 medium (Chen et al.,
2011)without FGF2 and transforming growth factor b but
supplemented with 10 mM CHIR99021 (Tocris, 4423). Loss of plu-
ripotency was confirmed by an RT-qPCR panel of self-renewal,
mesoderm, endoderm, and ectoderm genes (Table S1) and by
immunofluorescence staining and imaging of NANOG.Fibroblast Cell Culture
Fibroblasts (ATCC, CRL2429) were grown in Iscove’smodifiedDul-
becco’s medium (Thermo Fisher Scientific, 12440053) with 20%
fetal bovine serum (HyCLone, SV30160.03). Cells were passaged
using TrypLE cell dissociation enzyme (Thermo Fisher Scientific,
12504013) following the manufacturer’s guidelines. Cells were
maintained at 37C and 5% CO2 in a humidified incubator.Stem Cell Reports j Vol. 14 j 1009–1017 j June 9, 2020 1015
Nucleoside Supplementation
EmbryoMax Nucleosides 100X (Merck, ES-008-D) were added to
mTeSR, E8, Nutristem, or StemBeads cell culture media at a final
concentration of 0.53 (15mM cytidine, 15mM guanosine, 15mM
uridine, 15mM adenosine, and 6mM thymidine). All experiments
were performed after 72 h in culture with the supplementation
of nucleosides.SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2020.04.004.AUTHOR CONTRIBUTIONS
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